PURPOSE. Epidermal growth factor (EGF) and related growth factors: transfor
ming growth factor (TGF)-alpha, heparin-binding (HB)-EGF, and amphiregulin
(AR), have been shown to stimulate events associated with epithelial wound
repair. These growth factors function by binding to 1 common EGF receptor (
EGFR), tyrosine kinase. We have used in vivo and organ culture wound-heatin
g models to examine the kinetics and extent of EGFR activation during corne
al epithelial wound repair and whether the epithelium itself produces EGFR
ligands capable of stimulating the healing process.
METHODS. In the in vivo model. 3-mm debridement wounds were made in rat cor
neas and allowed to heal in situ. Activation of EGFR was analyzed by 1) ind
irect immunofluorescence microscopy, 2) immunoprecipitation using anti-EGFR
and anti-phosphotyrosine (anti-PT), and 3) binding-site localization using
EGF-fluorescein isothiocyanate (FITC). Relative levels of mRNA fur EGF. TG
F-alpha, HB-EGF, and AR were determined using reverse transcription-polymer
ase chain reaction. To determine whether inhibiting EGFR activation slows e
pithelial migration, wounded corneas were allowed to heal in organ culture
in the presence of tyrphostin AG1478 (0-50 mu M), a specific inhibitor of E
GFR kinase activity.
RESULTS. In unwounded corneas, EGFR was localized in basal cells and appear
ed to be membranous. Within 1 hour after wounding, EGFR was no longer immun
olocalized in the membranes of cells migrating into the wound area. EGF-FIT
C-binding assays indicated that EGFR ligands could penetrate all the way to
the limbus. Immunoprecipitation showed that EGFR was phosphorylated on tyr
osine residues within 30 minutes after wounding and that phosphorylation le
vels increased after wounding. Levels of mRNA for TGF-alpha. HB-EGF, and AR
all appeared to increase after wounding. In organ culture experiments, tyr
phostin AG1478 inhibited migration rates in a dose-dependent manner.
CONCLUSIONS. These data indicate that EGFR was activated during corneal epi
thelial wound healing in vivo. Furthermore, this activation appears to be a
necessary component of the process, because inhibition of the EGFR signali
ng cascade significantly slowed migration rates.